Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
PTPRC and prostate cancer are reported together in 1 article.
Gene
PTPRC
- HGNC
- HGNC:9666
4articles
4mentions
1variants with confirmed gene link
Most co-reported phenotypes (articles)
Reported variants (articles · ClinVar status)
Phenotype
Prostate cancer
218articles
218mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
1 records shown · first 60Splice-disrupt genomic variants in prostate cancer.
PMID 35286517 | PMCID PMC9262760 | DOI 10.1007/s11033-022-07257-9 · Molecular biology reports · 2022 · 9 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | PTPRC | “Some splice-disrupt variants, located on coding sequences of NCOR2, PTPRC, and CRP, were solely present in the advanced metastatic castration-resistant prostate cancer.” | 0.98 | hgnc_dict_v1 |
| phenotype | prostate cancer | “Splice-disrupt genomic variants in prostate cancer.” | 0.98 | phenotype_alias_lexicon_v2 |
| gene | HLA-A | “HLA-A in prostate cancer, MSR1 in familial prostate cancer, and EGFR in both castration-resistant prostate cancer and metastatic castration-resistant had the highest allele frequencies of splice-disrupt variations.” | 0.98 | hgnc_dict_v1 |
| gene | MSR1 | “HLA-A in prostate cancer, MSR1 in familial prostate cancer, and EGFR in both castration-resistant prostate cancer and metastatic castration-resistant had the highest allele frequencies of splice-disrupt variations.” | 0.98 | hgnc_dict_v1 |